Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • AstraZeneca and Merck decision to disinvest in the UK is a ‘tragedy’ for British research and innovation

    September 17, 2025 | AstraZeneca, Merck, clinical trials, patient recruitment 

    Kate Shaw comments on the latest news about AstraZeneca and Merck’s decision to hold planned investments in the UK

    - PMLiVE

    The recent decision by pharmaceutical company AstraZeneca to pause a planned £200 million expansion of its Cambridge research site and the announcement by Merck (known as MSD in Europe) to withdraw its life science research operation from the UK have been described as a ‘tragedy’ by Innovative Trials’ founder and CEO, Kate Shaw.

     

    Read more here: https://innovativetrials.com/astrazeneca-and-merck-decision-to-disinvest-in-uk-is-a-tragedy-for-british-research-and-innovation-says-innovative-trials/

    This content was provided by Innovative Trials

    Company Details

    - PMLiVE

    Innovative Trials

    Email
    Website

     Latest Content from  Innovative Trials 

    Kate Shaw reflects on Innovative Trials’ first US office openings

    On Thanksgiving, Kate Shaw, Founder and CEO of Innovative Trials, reflects on the company first US office opening

    Innovative Trials on the latest ABPI report

    Kate Shaw, Innovative Trials Founder & CEO, commented on the latest ABPI report

    Innovative Trials featuring in a Clinical Trials Arena article

    Leanne Keem, Head of Operations and Client Relationship at Innovative Trials, featured in a recent article.

    Overcoming Patient Recruitment Challenges in Rare Disease Trials

    Rare diseases are thought to affect up to 446 million people worldwide. With more than 7,000 rare diseases, most of which are genetic, it’s vital all patients can access new...

    FREE Live Webinar – Overcoming Patient Recruitment Challenges in Rare Disease Trials

    Innovative Trials and Pfizer invite you to attend the live webinar

    Innovative Trials opens first US office

    We are incredibly excited to announce the opening of our very first US office! This is an incredible milestone towards our mission to accelerate clinical development. Read the full press...

    Accelerating patient recruitment post-COVID-19

    COVID-19 has hugely affected clinical trials and patient recruitment, with the entire industry on hold for some time causing backlogs and delays most of the studies.

    Innovative Trials opens first US office

    The leading global patient recruitment organisation has opened its first international office in the Raleigh, North Carolina

    Windrush Day

    Innnovative Trials' Equality & Diversity committee raises awareness around Windrush Day and the Windrush generation

    Celebrating World Blood Donor Day

    Each 14th June World Blood Donor day is celebrated around the world to spread awareness around the importance of giving blood.